COVID vaccine supply deal dispute: JnJ to pay USD 50 million to Emergent Ruchika Sharma9 July 2024 5:49 PM ISTEmergent BioSolutions has said that Johnson & Johnson has agreed to settle claims arising from the termination of the manufacturing deal for the...
JnJ gets USFDA, European Commission nod for Sirturo Ruchika Sharma7 July 2024 4:15 PM ISTBeerse: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has issued traditional approval for SIRTURO...
JnJ completes acquisition of Proteologix Ruchika Sharma23 Jun 2024 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held...
JnJ submits application to USFDA for Subcutaneous amivantamab for patients with EGFR-mutated non-small cell lung cancer Ruchika Sharma19 Jun 2024 3:56 PM ISTRaratin: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration...
Johnson and Johnson reaches USD 700 million talc settlement with US states Ruchika Sharma12 Jun 2024 11:30 AM ISTNew York: Johnson & Johnson has reached a settlement of $700 million to resolve an investigation by 42 U.S. states and Washington, D.C....
JnJ submits application to USFDA for expansion of Pediatric indication for HIV-1 Therapy Prezcobix Ruchika Sharma5 Jun 2024 1:00 PM ISTTitusville: Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug...
Johnson & Johnson concludes acquisition of Shockwave Medical Ruchika Sharma2 Jun 2024 3:31 PM ISTNew Brunswick: Johnson & Johnson has announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson &...
Johnson & Johnson Executive Vice President William N Hait to retire Ruchika Sharma1 Jun 2024 2:15 PM ISTNew Brunswick: Johnson & Johnson has announced that William N. (Bill) Hait, M.D., Ph.D., will retire from his position as Executive Vice...
JnJ to buy rights to Numab Therapeutics Clinical-Stage Bispecific Antibody NM26 Ruchika Sharma29 May 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage...
Johnson and Johnson Gets CDSCO Panel Nod For Additional Indication of Daratumumab to Treat Light chain AL amyloidosis Dr. Divya Colin25 May 2024 6:00 PM ISTNew Delhi: Granting local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Johnson & Johnson to acquire Proteologix for USD 850 million in cash Ruchika Sharma20 May 2024 4:23 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held...
JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease Ruchika Sharma5 May 2024 1:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced it has submitted applications to the European Medicines...
